THURSDAY, Aug. 23, 2018 (HealthDay News) — A new subtype of multiple sclerosis (MS) has been identified by researchers, and the discovery changes understanding of the disease. MS has long been considered a disease of the brain’s white matter, where immune cells destroy the fatty protective covering (myelin) on nerveContinue Reading
These regimens raised the risk for disease relapse, study foundContinue Reading
Scans revealed less brain shrinkage in exercise groupContinue Reading
Study might explain why some multiple sclerosis patients stop understanding what others are feelingContinue Reading
Review found younger patients fared better over 5 years, though some deaths reportedContinue Reading
Pot shown to help chronic pain, chemo-related nausea and muscle spasms in multiple sclerosis, but researchers cite risks, tooContinue Reading
Specialist hopes ocrelizumab will be available by springContinue Reading
Perhaps, but researchers aren’t ready to recommend routine supplementation during pregnancyContinue Reading
Perhaps, but researchers aren’t ready to recommend routine supplementation during pregnancyContinue Reading
Study results suggest latitude affects timing of disease onsetContinue Reading
But significant side effects remain an issue for Lemtrada, researcher saysContinue Reading
Study shows no benefit, but staying active can help ease disease symptoms, experts sayContinue Reading
Laquinimod seemed to slow progression of the neurological disorder, but human trials neededContinue Reading
Laquinimod seemed to slow progression of the neurological disorder, but human trials neededContinue Reading